Eddy Saad

11PUBLICATIONS
147CO-AUTHORS
Predictive and prognostic markersBiologically active moleculesMolecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 11, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.

|Apr 28, 2026
The clinical landscape of HIF2α inhibitors in oncology.

|Feb 20, 2026
Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss.

Sabrina Y Camp, Meng Xiao He, Michael S Cuoco

|Jan 12, 2026
Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2.

Emre Yekedüz, Weiwei Bian, Stephanie E Siegmund

|Sep 18, 2025
HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 Inhibitors.

Muhannad Abu-Remaileh, Laura A Stransky, Nikita Bhalerao

|Sep 04, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.

Joao V Alessi, James R Lindsay, Anita Giobbie-Hurder

Pageof 2

Frequent Collaborators

10 joint publications

Toni K Choueiri

4 joint publications

Eliezer M Van Allen

4 joint publications

Marc Machaalani

4 joint publications

Ziad Bakouny